MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors’ Efficacy in Neuroblastoma CellsPiergiuseppe De Rosa, Giovanni Perini|International Journal of Molecular Sciences|2023Cited by 8
24 (PB012): Runx1t1 is an epigenetic regulator essential for MYCN-driven neuroblastoma tumorigenesisMurray D. Norris, Michelle Haber, Emanuele Valli et al.|European Journal of Cancer|2024Cited by 0